Ciprodex Dosage for 6-Month-Old
For a 6-month-old infant, Ciprodex (ciprofloxacin 0.3%/dexamethasone 0.1%) is dosed as 4 drops into the affected ear twice daily for 7 days for acute otitis externa or acute otitis media with tympanostomy tubes. 1, 2
Administration Details
The FDA-approved dosing for infants 6 months and older is straightforward:
- Dose: 4 drops (0.14 mL) into affected ear
- Frequency: Twice daily (every 12 hours)
- Duration: 7 days
- Indications: Acute otitis externa OR acute otitis media with tympanostomy tubes 1, 2
Each 4-drop dose delivers 0.42 mg ciprofloxacin and 0.14 mg dexamethasone 1, 2.
Critical Administration Technique
Proper instillation technique is essential for efficacy:
- Shake the bottle well immediately before each use
- Warm the bottle by holding in hand for 1-2 minutes to prevent dizziness from cold suspension
- Position infant with affected ear upward
- Instill 4 drops into ear canal
- For tympanostomy tubes: Pump the tragus 5 times by pushing inward to facilitate middle ear penetration 2
- For otitis externa: Maintain position for 60 seconds to allow canal penetration 1
- Repeat for opposite ear if bilateral disease
- Discard unused portion after completing therapy 1, 2
Evidence Supporting Use in This Age Group
The FDA approval for age 6 months and older is based on robust pediatric data. Studies demonstrate that topical ciprofloxacin/dexamethasone achieves superior outcomes compared to oral antibiotics, with median time to cessation of otorrhea of 4 days versus 7 days with oral amoxicillin-clavulanate 3. Clinical cure rates reach 85-90% in pediatric patients 3, 4.
The combination of ciprofloxacin plus dexamethasone is superior to ciprofloxacin alone, reducing time to cessation of otorrhea by approximately 1 day (4.22 vs 5.31 days), which represents a clinically meaningful 20% reduction 5.
Safety Considerations
Topical fluoroquinolones do not carry the systemic toxicity concerns of oral fluoroquinolones 6. The American Academy of Pediatrics guidelines explicitly state that systemic toxicity is not a concern with topical therapy 6.
Important Caveats:
- Contraindicated in viral infections (including herpes simplex) and fungal otic infections 1
- Discontinue if hypersensitivity reaction occurs 1
- If otorrhea persists after full 7-day course or recurs (≥2 episodes within 6 months), further evaluation is needed to exclude cholesteatoma, foreign body, or tumor 1
- For otic use only—not for ophthalmic use or injection 1
Clinical Context
This dosing applies specifically to acute otitis externa (swimmer's ear) or acute otitis media with tympanostomy tube otorrhea in patients 6 months and older. The pathogens targeted include Pseudomonas aeruginosa and Staphylococcus aureus for otitis externa 1, which are the most common organisms in these conditions.
The addition of dexamethasone provides anti-inflammatory benefits that accelerate resolution of symptoms and is particularly effective for reducing granulation tissue formation, with 81.3% reduction by day 11 compared to 56.1% with ofloxacin alone 7.